Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Counterregulation

Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Counterregulation

Conditions: Diabetes; Hypoglycemia
Interventions: Other: hyperinsulinemic-hypoglycemic clamp; Other: 13C-MRS procedure/Acetate infusion
Sponsors: Pennington Biomedical Research Center
Suspended

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 18, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments